Related Experiment Video
Updated: Apr 11, 2026

Phage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coli
Published on: March 20, 2016
Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies
Russell J Krom1,2,3,4, Prerna Bhargava1,5,3, Michael A Lobritz1,5,3,6
1†Institute for Medical Engineering and Science, Department of Biological Engineering, and Synthetic Biology Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Engineered bacterial phagemids expressing antimicrobial peptides and toxins offer a novel, nonantibiotic approach to combat drug-resistant infections. This method achieves rapid bacterial death without the harmful side effects of traditional bacteriophage therapy.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Antibiotic resistance poses a significant global health challenge.
- Conventional antibiotic development struggles to match the rise of resistant bacterial strains.
- Bacteriophage therapy, while promising, can cause adverse effects due to endotoxin release.
Purpose of the Study:
- To engineer bacterial phagemids for expressing antimicrobial peptides (AMPs) and protein toxins.
- To develop a novel, nonlytic antibacterial strategy.
- To assess the efficacy of engineered phagemids in a preclinical model.
Main Methods:
- Phagemid engineering to encode multiple AMPs and protein toxins.
- Demonstration of modularity in phagemid design.
- In vivo testing in a murine peritonitis infection model.
Main Results:
- Engineered phagemids induce rapid, nonlytic bacterial death.
- The phagemid system is highly modular, allowing flexible customization.
- Effective treatment of bacterial infections was shown in a murine model.
Conclusions:
- Engineered phagemid therapy presents a viable, nonantibiotic alternative for treating bacterial infections.
- This approach circumvents the safety concerns associated with lytic and replicative bacteriophages.
- Targeted phagemid therapy offers a promising strategy against antibiotic-resistant bacteria.
Related Concept Videos
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Antibiotic Selection
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Plasmids

